Related Experiment Video
Updated: Jun 21, 2025
07:59
Therapy Interventions for Upper Limb Amputees Undergoing Selective Nerve Transfers
Published on: October 29, 2021
3.4K
Trimodal prehabilitation in oncogynaecology
Ceska Gynekologie
|July 5, 2024
Summary
Prehabilitation, involving physiotherapy, nutrition, and psychological support before surgery, improves patient recovery. This approach enhances functional capacity, reduces complications, and lowers treatment costs.
Area of Science:
- Oncology
- Surgical Recovery
- Preventive Medicine
Background:
- Prehabilitation enhances patient endurance and functional capacity before stressful events like oncogynaecological surgery.
- Current prehabilitation strategies integrate physiotherapy, nutritional support, and psychological support.
- Emerging modalities are continuously being incorporated into prehabilitation programs.
Purpose of the Study:
- To evaluate the impact of prehabilitation on postoperative recovery in oncogynaecological surgery patients.
- To assess the effectiveness of combined preoperative interventions in reducing complications and hospital stay.
- To determine the cost-effectiveness of prehabilitation in cancer treatment.
Main Methods:
- Review of existing studies on prehabilitation interventions.
- Analysis of combined physiotherapy, nutritional, and psychological support modalities.
- Assessment of patient outcomes, including complication rates and hospital duration.
Main Results:
- Combined preoperative interventions positively influence postoperative recovery.
- Prehabilitation significantly reduces the risk of perioperative and postoperative complications.
- Shorter hospital stays were observed in patients undergoing prehabilitation, leading to reduced treatment costs.
Conclusions:
- Prehabilitation is an effective strategy for improving outcomes in oncogynaecological surgery.
- Multimodal prehabilitation, including physical, nutritional, and psychological support, enhances patient recovery.
- Implementing prehabilitation can lead to significant cost savings in cancer care.
Related Concept Videos
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
01:21Cancer Survival Analysis
340
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
340